Concepedia

Publication | Open Access

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

DOIFull Paper Access

315

Citations

33

References

2019

Year

Kassem Bourgi, Peter F. Rebeiro, Megan Turner, Jessica L. Castilho, Todd Hulgan, Stephen Raffanti, John R. Koethe, Timothy R. Sterling
Clinical Infectious Diseases

Abstract

Treatment-naive PLWH starting dolutegravir-based regimens gained significantly more weight at 18 months than those starting NNRTI-based and elvitegravir-based regimens.

References

YearCitations

Page 1